| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/28/2008 | EP1711177B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1658039B1 Use of biotin or a biotin derivative with vitamin c for lightening skin and treating age spots |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1438014B1 Oil-in-water emulsion containing non-polar active principles |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1391194B1 Preparation for hair and/or scalp |
| 05/28/2008 | EP1233930B1 A particle comprising a host lattice and a guest, its preparation and use in ultraviolet light screening compositions |
| 05/28/2008 | CN101189227A New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 05/28/2008 | CN101189023A 监测和调制hgf/hgfr活性 Monitoring and modulation hgf / hgfr activity |
| 05/28/2008 | CN101189017A Method of using oxidative reductive potential water solution in dental applications |
| 05/28/2008 | CN101189009A Dermatological compositions and salts for the treatment of dermatological diseases |
| 05/28/2008 | CN101189008A Oxaprozin or closely related compound for the treatment and prevention of diseases |
| 05/28/2008 | CN101185748A Traditional Chinese medicine preparation for eliminating naevus and stains |
| 05/28/2008 | CN101185741A Fumigation and cleaning medicine for treating tinea unguium |
| 05/28/2008 | CN101185736A Orally-administered traditional Chinese medicine for treating acute lupus erythematosus |
| 05/28/2008 | CN101185731A Externally-applied medicine for treating chronic eczema |
| 05/28/2008 | CN101185729A Fumigation and cleaning medicine for treating psoriasis |
| 05/28/2008 | CN101185728A Infusion medicine for treating tinea unguium |
| 05/28/2008 | CN101185722A Infusion medicine for treating beriberi |
| 05/28/2008 | CN101185720A Formula of hair tonic preparations and preparation method |
| 05/28/2008 | CN101185715A Chinese herbal medicine for treating psoriasis |
| 05/28/2008 | CN101185714A Externally-cleaned medicine for treating skin moisture fester |
| 05/28/2008 | CN101185705A Cream shape medicine for treating impetigo |
| 05/28/2008 | CN101185703A Externally-cleaned medicine for treating furuncle |
| 05/28/2008 | CN101185696A Cream shape medicine for treating II or III degree bedsore |
| 05/28/2008 | CN101185686A Powder agent medicine for treating eczema |
| 05/28/2008 | CN101185675A Tea tree oil speckle-removing agent and preparation method thereof |
| 05/28/2008 | CN101185674A Infusion medicine for treating tinea pedis |
| 05/28/2008 | CN101185658A Intermediate compound of a liquid state traditional Chinese medicinal preparation and preparation method and application thereof |
| 05/28/2008 | CN101185618A Multifunctional skin disease shower lotion and fit facilities bathing urn |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390134C Compositions for treating acne comprising phytandiol amine |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389820C Therapeutic agent comprising botulinum neurotoxin |
| 05/28/2008 | CN100389818C Medicinal soap for treating pruritus and preparation method thereof |
| 05/28/2008 | CN100389810C Medicine for eliminating acne |
| 05/28/2008 | CN100389808C Acne-treating medicinal soap and preparation method thereof |
| 05/28/2008 | CN100389800C Medicinal preparation for treating cold abscess and all kinds of body surface ulcer |
| 05/28/2008 | CN100389790C Preparing method of medicine for treating burns or scald |
| 05/28/2008 | CN100389776C Use of CM101 in preparing medicine |
| 05/28/2008 | CN100389756C Powdery wound paste with instant soluble seal and production thereof |
| 05/28/2008 | CA2569204A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
| 05/27/2008 | US7378551 gelling agent having a high ability of gelling an oily base which is capable of giving a gel composition having a strong gel strength and a good transparency, a gel composition having a strong gel strength and a good transparency, an external composition having a good feel upon use, a cosmetic |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378500 below the kneecap in a diabetic subject; administering agonist of the non-proteolytically activated thrombin receptor |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 05/27/2008 | US7378428 phosphodiesterase inhibitors; (Z)-2-(7-bromomethyl-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-(adamantan-1-yl)ethan-1-one; graft versus host disease, osteoporosis, bone fracture, restenosis, arteriosclerosis, obesity, ischemic reperfusion injury, depression, allergies, transplant rejection |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378408 Methods of treatment and formulations of cephalosporin |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | CA2575873A1 Spray mixture for soothing a cow udder |
| 05/27/2008 | CA2256960C High glycerin containing anti-microbial cleansers |
| 05/22/2008 | WO2008060130A2 Detergent compositions in the form of microemulsions and use thereof in the treatment of alopecia |
| 05/22/2008 | WO2008059927A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | WO2008059906A1 External preparation for skin and external preparation for mucosa |
| 05/22/2008 | WO2008059905A1 Raw material for oral product and oral product using the same |
| 05/22/2008 | WO2008059870A1 Heat shock protein inducer, skin preparation for external use, food and drug containing the same, and method of producing heat shock protein inducer |
| 05/22/2008 | WO2008059869A1 Method of degrading polysaccharide |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059819A1 Seaweed-derived immunostimulant and antiinflammatory agent |
| 05/22/2008 | WO2008059224A1 Use of buprenorphine or n-alkylated derivatives thereof for wound healing |
| 05/22/2008 | WO2008059190A1 Treatment of excess sebum production |
| 05/22/2008 | WO2008059127A1 Peptide-containing pharmaceutical and/or cosmetic composition |
| 05/22/2008 | WO2008059074A1 Stabilisation of aloe vera extract |
| 05/22/2008 | WO2008040516A3 Microbiological composition and use thereof |
| 05/22/2008 | WO2008039751A3 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 05/22/2008 | WO2008037497A3 Galectin-2 for the treatment of inflammatory diseases of the skin |
| 05/22/2008 | WO2008023003A8 Drug combinations for treating airway diseases |
| 05/22/2008 | WO2008017521A3 Compositions with enhanced elasticizing activity |
| 05/22/2008 | US20080119936 Intervertebral disc |
| 05/22/2008 | US20080119781 Method and apparatus for treating scar tissue |
| 05/22/2008 | US20080119560 Use treating glaucoma, ocular hypertension, or baldness; prostaglandin EP2 selective agonists are 1-hydroxy-3-chloro-4-carboxylalk(en)yl-5-(aryloxyalkyl)cyclopentanes |
| 05/22/2008 | US20080119558 Drug for Inhibiting Production of Matrix Metalloprotease-9 |
| 05/22/2008 | US20080119551 Skin cosmetics comprising a cystine derivative and a chemical peeling agent, a bactericide, an anionic sufactant, or a cationic surfactant |
| 05/22/2008 | US20080119546 Treatment of hyperproliferative conditions of body surfaces |
| 05/22/2008 | US20080119530 Topically administrating an inhibitor of Erbb2 or HER2 receptor tyrosine kinase activity because of a novel connection between HER2 and a DNA damage checkpoint; reducing mutagenesis and apoptosis; antitumor, -carcinogenic, -proliferative agents and -inflammatory agents; sunburn; hyperplasia |
| 05/22/2008 | US20080119528 use of specific cyklolignans |
| 05/22/2008 | US20080119527 Composition for combating the localized hyperpigmentation of dark skin |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119509 Nontoxic; asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), eosinophilic granuloma, psoriasis |
| 05/22/2008 | US20080119496 7-Substituted Purine Derivatives for Immunosuppression |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
| 05/22/2008 | US20080119462 Method for treating vascular hyperpermeable disease |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 05/22/2008 | US20080118586 Medicated cream for topical application |
| 05/22/2008 | US20080118581 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside |